2024
OncoSexome: the landscape of sex-based differences in oncologic diseases
Shen X, Zhang Y, Li J, Zhou Y, Butensky S, Zhang Y, Cai Z, DeWan A, Khan S, Yan H, Johnson C, Zhu F. OncoSexome: the landscape of sex-based differences in oncologic diseases. Nucleic Acids Research 2024, gkae1003. PMID: 39535034, DOI: 10.1093/nar/gkae1003.Peer-Reviewed Original Research
2022
Associations of 3-monochloropropane-1,2-diol and glycidol with prevalence of metabolic syndrome: Findings from Lanxi Nutrition and Safety Study
Wan X, Jia W, Zhuang P, Wu F, Zhang Y, Shen X, Liu X, Zheng W, Jiao J, Zhang Y. Associations of 3-monochloropropane-1,2-diol and glycidol with prevalence of metabolic syndrome: Findings from Lanxi Nutrition and Safety Study. Environmental Research 2022, 209: 112746. PMID: 35063427, DOI: 10.1016/j.envres.2022.112746.Peer-Reviewed Original ResearchConceptsMetS prevalenceMetS casesRisk factorsAdult Treatment Panel III criteriaNational Cholesterol Education ProgramCholesterol Education ProgramBehavioral risk factorsPotential risk factorsUrinary creatinine contentPositive associationChinese elderly peoplePoisson regression modelsHypertriglyceridemia prevalencePrevalent MetSMetabolic syndromeUrinary biomarkersLowest quartileHigh prevalenceRelative riskElderly populationMercapturic acidsDietary exposurePrevalenceSafety studiesStrong positive association